Showing results (261-270 of 777) with videos related to
Sort By:
Pageof 78
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2015
Multiple myeloma: new uses for available agents, excitement for the futureKenneth C AndersonSeminars in Oncology|April 1, 2005
Clinical update: novel targets in multiple myelomaKenneth C AndersonJournal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
Therapeutic advances in relapsed or refractory multiple myelomaKenneth C AndersonSeminars in Hematology|December 14, 2005
Lenalidomide and thalidomide: mechanisms of action--similarities and differencesKenneth C AndersonExperimental Hematology|March 24, 2007
Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactionsKenneth C AndersonCancer Treatment and Research|October 4, 2016
Vision Statement for Multiple Myeloma: Future DirectionsKenneth C AndersonBlood|July 24, 2010
Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myelomaGüllü Görgün, Elisabetta Calabrese, Ender Soydan, et al.Blood Cancer Journal|February 3, 2023
Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeuticsDaisuke Ogiya, Zuzana Chyra, Sigitas J Verselis, et al.Blood|March 25, 2016
Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1Paul G Richardson, Todd M Zimmerman, Craig C Hofmeister, et al.Pageof 78